About Main Military Clinical Hospital named after N.N. Burdenko
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Main Military Clinical Hospital named after N.N. Burdenko
During the past decade, Main Military Clinical Hospital named after N.N. Burdenko conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 10 clinical trials were completed, i.e. on
average, 52.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Main Military Clinical Hospital named after N.N. Burdenko" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Mannkind Corporation" with 6 trials
sponsored, "Biocad" with 3 trials sponsored, "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 2 trials sponsored and "Celgene"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Main Military Clinical Hospital named after N.N. Burdenko"
#1 collaborator was "BeiGene" with 1 trials as a collaborator, "Main military clinical hospital named after academician N. N. Burdenko" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Main Military Clinical Hospital named after N.N. Burdenko
According to Clinical.Site data, the most researched conditions in "Main Military Clinical Hospital named after N.N. Burdenko" are
"Non-Small Cell Lung Cancer" (4 trials), "Diabetes Type 2" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Main Military Clinical Hospital named after N.N. Burdenko" in a lesser frequency.
Clinical Trials Intervention Types at Main Military Clinical Hospital named after N.N. Burdenko
Most popular intervention types in "Main Military Clinical Hospital named after N.N. Burdenko" are "Drug" (21 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (6 trials), "Placebo" (6 trials), "Gemcitabine" (5 trials), "Pemetrexed" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Main Military Clinical Hospital named after N.N. Burdenko
The vast majority of trials in "Main Military Clinical Hospital named after N.N. Burdenko" are
26 trials for "All" genders.
Clinical Trials Status at Main Military Clinical Hospital named after N.N. Burdenko
Currently, there are NaN active trials in "Main Military Clinical Hospital named after N.N. Burdenko".
undefined are not yet recruiting,
2 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Main Military Clinical Hospital named after N.N. Burdenko,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Main Military Clinical Hospital named after N.N. Burdenko, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".